• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

波兰儿童多系统炎症综合征的特征。

Distinct characteristics of multisystem inflammatory syndrome in children in Poland.

机构信息

Department of Pediatric Infectious Diseases, Wroclaw Medical University, Chałubińskiego 2-2a, 50-368, Wrocław, Poland.

Department of Pediatrics with Clinical Assessment Unit, Medical University of Warsaw, Żwirki i Wigury 61, 02-091, Warsaw, Poland.

出版信息

Sci Rep. 2021 Dec 7;11(1):23562. doi: 10.1038/s41598-021-02669-2.

DOI:10.1038/s41598-021-02669-2
PMID:34876594
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8651720/
Abstract

During the winter months of 2020/2021 a wave of multisystem inflammatory syndrome in children (MIS-C) emerged in Poland. We present the results of a nationwide register aiming to capture and characterise MIS-C with a focus on severity determinants. The first MIS-C wave in Poland was notably high, hence our analysis involved 274 children. The group was 62.8% boys, with a median age of 8.8 years. Besides one Asian, all were White. Overall, the disease course was not as severe as in previous reports, however. Pediatric intensive care treatment was required for merely 23 (8.4%) of children, who were older and exhibited a distinguished clinical picture at hospital admission. We have also identified sex-dependent differences; teenage boys more often had cardiac involvement (decreased ejection fraction in 25.9% vs. 14.7%) and fulfilled macrophage activation syndrome definition (31.0% vs. 15.2%). Among all boys, those hospitalized in pediatric intensive care unit were significantly older (median 11.2 vs. 9.1 years). Henceforth, while ethnicity and sex may affect MIS-C phenotype, management protocols might be not universally applicable, and should rather be adjusted to the specific population.

摘要

2020/2021 年冬季,波兰出现了一波儿童多系统炎症综合征(MIS-C)。我们报告了一项全国性登记研究的结果,旨在捕捉和描述 MIS-C,并重点关注严重程度的决定因素。波兰的第一波 MIS-C 非常高,因此我们的分析涉及 274 名儿童。该组中 62.8%为男孩,中位年龄为 8.8 岁。除了一名亚洲人外,所有儿童均为白人。总体而言,疾病过程并不像之前的报告那样严重,但仍有 23 名(8.4%)儿童需要儿科重症监护治疗,他们年龄较大,入院时表现出明显的临床特征。我们还发现了性别相关的差异;青少年男孩更常出现心脏受累(射血分数降低 25.9%比 14.7%)和符合巨噬细胞活化综合征的定义(31.0%比 15.2%)。在所有男孩中,那些在儿科重症监护病房住院的男孩年龄明显更大(中位数 11.2 岁比 9.1 岁)。因此,虽然种族和性别可能影响 MIS-C 表型,但管理方案可能并非普遍适用,而应根据特定人群进行调整。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d7/8651720/bf8e5757f37a/41598_2021_2669_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d7/8651720/c6c7a84a282a/41598_2021_2669_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d7/8651720/5a92b1e5d457/41598_2021_2669_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d7/8651720/bf8e5757f37a/41598_2021_2669_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d7/8651720/c6c7a84a282a/41598_2021_2669_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d7/8651720/5a92b1e5d457/41598_2021_2669_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d7/8651720/bf8e5757f37a/41598_2021_2669_Fig3_HTML.jpg

相似文献

1
Distinct characteristics of multisystem inflammatory syndrome in children in Poland.波兰儿童多系统炎症综合征的特征。
Sci Rep. 2021 Dec 7;11(1):23562. doi: 10.1038/s41598-021-02669-2.
2
Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain.儿童和青少年中严重的 SARS-CoV-2 表现:从 COVID-19 肺炎到多系统炎症综合征:西班牙儿科重症监护病房的一项多中心研究。
Crit Care. 2020 Nov 26;24(1):666. doi: 10.1186/s13054-020-03332-4.
3
Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Children: One Year after the Onset of the Pandemic in a High-Incidence Area.儿童感染 SARS-CoV-2 后发生的多系统炎症综合征:在高发病率地区大流行一年后。
Viruses. 2021 Oct 7;13(10):2022. doi: 10.3390/v13102022.
4
Multisystem inflammatory syndrome in children rose and fell with the first wave of the COVID-19 pandemic in France.儿童多系统炎症综合征在法国随着新冠疫情的第一波高峰出现和消退。
Acta Paediatr. 2021 Mar;110(3):922-932. doi: 10.1111/apa.15667. Epub 2020 Dec 21.
5
Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study.美国儿童多系统炎症综合征(MIS-C)严重结局相关因素:一项回顾性监测研究。
Lancet Child Adolesc Health. 2021 May;5(5):323-331. doi: 10.1016/S2352-4642(21)00050-X. Epub 2021 Mar 10.
6
Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).儿童多系统炎症综合征(MIS-C)中 SARS-CoV-2 血清学的定量分析。
Pediatrics. 2020 Dec;146(6). doi: 10.1542/peds.2020-018242. Epub 2020 Sep 2.
7
Multisystem inflammatory syndrome (MIS-C) in Pakistani children: A description of the phenotypes and comparison with historical cohorts of children with Kawasaki disease and myocarditis.巴基斯坦儿童多系统炎症综合征(MIS-C):表型描述及与川崎病和心肌炎患儿历史队列的比较。
PLoS One. 2021 Jun 21;16(6):e0253625. doi: 10.1371/journal.pone.0253625. eCollection 2021.
8
Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children.儿童严重急性呼吸综合征冠状病毒 2 诱导的多系统炎症综合征的独特临床和免疫学特征。
J Clin Invest. 2020 Nov 2;130(11):5942-5950. doi: 10.1172/JCI141113.
9
Pediatric Multisystemic Inflammatory Syndrome Temporarily associated with COVID-19: Clinical characteristics and management in a Pediatric Critical Care Unit.儿童多系统炎症综合征与 COVID-19 暂时相关:儿科重症监护病房的临床特征和管理。
Andes Pediatr. 2021 Jun;92(3):395-405. doi: 10.32641/andespediatr.v92i3.3333.
10
Severity of multisystem inflammatory syndrome in children (MIS-C) in patients with and without mucocutaneous findings.有和没有皮肤黏膜表现的儿童多系统炎症综合征(MIS-C)患者的严重程度。
Pediatr Dermatol. 2023 Mar;40(2):294-300. doi: 10.1111/pde.15243. Epub 2023 Jan 10.

引用本文的文献

1
Evaluation of clinical and laboratory findings in MIS-C patients associated with COVID-19: An experience from the Northwest of Iran.评估与 COVID-19 相关的 MIS-C 患者的临床和实验室检查结果:来自伊朗西北部的经验。
PLoS One. 2024 Nov 21;19(11):e0313843. doi: 10.1371/journal.pone.0313843. eCollection 2024.
2
In-hospital unfavorable outcomes of MIS-C during 2020-2022: a systematic review.2020-2022 年 MIS-C 住院期间不良结局的系统评价。
Eur J Pediatr. 2024 Dec;183(12):5071-5084. doi: 10.1007/s00431-024-05787-x. Epub 2024 Oct 1.
3
Complications of Multisystem Inflammatory Syndrome Associated with SARS-CoV-2 Infection-Many Facets of One Disease-A Literature Review Based on a Case Report.

本文引用的文献

1
Treatment of Multisystem Inflammatory Syndrome in Children.儿童多系统炎症综合征的治疗。
N Engl J Med. 2021 Jul 1;385(1):11-22. doi: 10.1056/NEJMoa2102968. Epub 2021 Jun 16.
2
Inflammatory biomarkers in COVID-19-associated multisystem inflammatory syndrome in children, Kawasaki disease, and macrophage activation syndrome: a cohort study.儿童新冠病毒相关多系统炎症综合征、川崎病和巨噬细胞活化综合征中的炎症生物标志物:一项队列研究
Lancet Rheumatol. 2021 Aug;3(8):e574-e584. doi: 10.1016/S2665-9913(21)00139-9. Epub 2021 Jun 8.
3
Epidemiology of Kawasaki Disease in Europe.
与SARS-CoV-2感染相关的多系统炎症综合征的并发症——一种疾病的多个方面——基于病例报告的文献综述
J Clin Med. 2024 Jul 16;13(14):4146. doi: 10.3390/jcm13144146.
4
Clinical presentation, diagnosis and management of multisystem inflammatory syndrome in children (MIS-C): a systematic review.儿童多系统炎症综合征(MIS-C)的临床表现、诊断和治疗:系统评价。
BMJ Paediatr Open. 2024 Jun 6;8(1):e002344. doi: 10.1136/bmjpo-2023-002344.
5
Should we be afraid of long-term cardiac consequences in children with multisystem inflammatory syndrome? Experience from subsequent waves of COVID-19.儿童多系统炎症综合征是否应担心长期心脏后果?来自 COVID-19 后续波次的经验。
Eur J Pediatr. 2024 Jun;183(6):2683-2692. doi: 10.1007/s00431-024-05528-0. Epub 2024 Mar 22.
6
Similarities and Differences between Multisystem Inflammatory Syndrome in Children (MIS-C) and Kawasaki Disease Shock Syndrome.儿童多系统炎症综合征(MIS-C)与川崎病休克综合征的异同
Children (Basel). 2023 Sep 8;10(9):1527. doi: 10.3390/children10091527.
7
Cardiac Involvement in Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) in Poland.波兰儿童多系统炎症综合征(MIS-C)患者的心脏受累情况。
Biomedicines. 2023 Apr 23;11(5):1251. doi: 10.3390/biomedicines11051251.
8
COVID-19 mRNA BNT162b2 vaccine immunogenicity among children with a history of paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS-TS).COVID-19 mRNA BNT162b2 疫苗在与 COVID-19 相关的儿童多系统炎症综合征(PIMS-TS)病史儿童中的免疫原性。
Vaccine. 2023 May 16;41(21):3317-3327. doi: 10.1016/j.vaccine.2023.04.035. Epub 2023 Apr 14.
9
Neuro-COVID-19 With or Without the Multisystem Inflammatory Syndrome (MIS-C): A Single-Center Study : COVID-19: Neurologic Manifestations in Children.神经 COVID-19 伴或不伴多系统炎症综合征(MIS-C):一项单中心研究:COVID-19:儿童的神经系统表现。
J Mol Neurosci. 2023 May;73(4-5):250-258. doi: 10.1007/s12031-023-02109-y. Epub 2023 Mar 28.
10
COVID-19 mRNA BNT162b2 vaccine safety and B-cell and T-cell reactogenicity among children with a history of paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS-TS) - preliminary study.COVID-19 mRNA BNT162b2 疫苗在与 COVID-19 相关的儿童多系统炎症综合征(PIMS-TS)病史患儿中的安全性以及 B 细胞和 T 细胞的致反应性 - 初步研究。
Vaccine. 2023 Mar 24;41(13):2289-2299. doi: 10.1016/j.vaccine.2023.02.072. Epub 2023 Mar 2.
欧洲川崎病的流行病学
Front Pediatr. 2021 May 25;9:673554. doi: 10.3389/fped.2021.673554. eCollection 2021.
4
Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2.美国 SARS-CoV-2 感染人群中儿童多系统炎症综合征的发病率。
JAMA Netw Open. 2021 Jun 1;4(6):e2116420. doi: 10.1001/jamanetworkopen.2021.16420.
5
Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 (PIMS-TS): Prospective, national surveillance, United Kingdom and Ireland, 2020.2020年英国和爱尔兰与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)相关的儿童多系统炎症综合征(PIMS-TS):前瞻性全国监测
Lancet Reg Health Eur. 2021 Apr;3:100075. doi: 10.1016/j.lanepe.2021.100075. Epub 2021 Mar 22.
6
Trends in Geographic and Temporal Distribution of US Children With Multisystem Inflammatory Syndrome During the COVID-19 Pandemic.美国儿童在 COVID-19 大流行期间出现多系统炎症综合征的地理和时间分布趋势。
JAMA Pediatr. 2021 Aug 1;175(8):837-845. doi: 10.1001/jamapediatrics.2021.0630.
7
Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study.美国儿童多系统炎症综合征(MIS-C)严重结局相关因素:一项回顾性监测研究。
Lancet Child Adolesc Health. 2021 May;5(5):323-331. doi: 10.1016/S2352-4642(21)00050-X. Epub 2021 Mar 10.
8
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19.美国儿童多系统炎症综合征(MIS-C)与严重急性 COVID-19 患儿的特征和结局比较。
JAMA. 2021 Mar 16;325(11):1074-1087. doi: 10.1001/jama.2021.2091.
9
Multisystem inflammatory syndrome in children related to COVID-19: a systematic review.儿童与 COVID-19 相关的多系统炎症综合征:系统评价。
Eur J Pediatr. 2021 Jul;180(7):2019-2034. doi: 10.1007/s00431-021-03993-5. Epub 2021 Feb 18.
10
Prevalence and Clinical Characteristics of SARS-CoV-2 Confirmed and Negative Kawasaki Disease Patients During the Pandemic in Spain.西班牙疫情期间新冠病毒检测呈阳性和阴性的川崎病患者的患病率及临床特征
Front Pediatr. 2021 Jan 18;8:617039. doi: 10.3389/fped.2020.617039. eCollection 2020.